Gilead Sciences Inc.
Gilead Sciences Inc. (GILD) — Form 144: Proposed sale of shares
AI-generated summary
Director Kelly Kramer proposed to sell 10,376 shares of Gilead Sciences Inc. common stock with an aggregate market value of $1,761,118.48 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares were acquired through the exercise of stock options on November 12, 2026. The proposed sale is associated with a trading plan adopted on August 13, 2026.
Key facts
- Seller
- KELLY KRAMER
- Relationship
- Director
- Shares to sell
- 10,376
- Market value
- $1,761,118.48
- Approximate sale date
- Nov 12, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 12, 2026 · Exercise of Stock Options
Rule 10b5-1 plan · adopted Aug 13, 2026
More GILD filings
- 4
Filed Nov 9, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 6, 2026
- SC 13G
Filed Nov 6, 2026
- 13F-HR
Filed Nov 5, 2026
- 144
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.